drugset / Trial / NCT02864264
Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
RandomizedParallel-groupDouble-blindScreening
Summary
The primary purpose of this study is to determine if single and multiple doses of BMS-986184 are safe and well tolerated in healthy male and female subjects. The primary purpose of the proof of mechanism study is to determine safety and efficacy in patients with ulcerative colitis.
Timeline
- Start
- 2016-09-14
- Primary completion
- 2017-09-27
- Completion
- 2017-09-27
Outcome
Outcome not reported
Stopped: “Adverse change in the risk/benefit”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986184 | Unknown | — | Intravenous |